The Annual Report and Financial Statements for the year ended
A copy of the 2019 Annual Report can be viewed on, and downloaded from, the Company's website at https://www.c4xdiscovery.com.
Contact:
Tel: (0)787 6444977
About
C4XD has a state-of-the-art suite of proprietary technologies across the Drug Discovery process and accesses further innovative capabilities and expertise through its growing network of partners. The Company is actively advancing its diverse pre-clinical discovery portfolio which is focused on inflammation, neurodegeneration and oncology (including immuno-oncology). Opportunities to maximise value from the portfolio are proactively driven by C4XD's commercial division. The Company is led by a highly experienced management team and Board who have delivered significant value creation within the healthcare sector.
(C) 2020 Electronic News Publishing, source